InvestorsHub Logo
Followers 2
Posts 2139
Boards Moderated 0
Alias Born 12/19/2016

Re: Cheekie post# 54180

Sunday, 11/18/2018 3:58:43 PM

Sunday, November 18, 2018 3:58:43 PM

Post# of 58862
Biowell seems to be doing well:


The leader in living biotechnology!

In 1999, Biowell brought in a team of technical specialists who were experts in the field of biotechnology research. They brought with them the seeds of a mature technology (including mass production technology and important patents). Their many years of research and sales experience were essential to the company’s rapid rise and early success. DNA products are the focus of Biowell’s business, and is the world’s first private biotechnology company to research and produce DNA products that can be used in everyday life.
Biowell’s biggest competitive advantage is its world-class patented technology.
Biowell has a number of biochemistry experts with masters and PhD degrees, and also has a state-of-art laboratory, with the CNLA laboratory certification. Biowell is not only the market leader of the services of DNA Parentage Testing, DNA Bank and SNP Gene Analysis but also the exclusive distributor of the well-known Swedish Pyrosequencing instruments in Taiwan. Biowell is also negotiating the distribution rights with many big companies for their instruments, equipments, accessories etc. to provide more choices to the clients.

In addition, to match the market trends and demands, Biowell is continuously developing and launching new products such as DNA vaccines and New Biomass Power. Our next research project is to develop Chinese herbal medicine. It is hoped that in the future, our research will make even larger contributions to the field of biotechnology. At the same time, Biowell is collaborating with major medical research institutes around the country to develop superior molecular biology test technologies, creating a better future for people everywhere.





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APDN News